Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

2015319 citationsJournal Articlehybrid Open Access

Authors

Ian Pavord · University of Oxford

Sally Lettis

Nicholas Locantore · GlaxoSmithKline (China)

Steve Pascoe · Research Triangle Park Foundation

Paul Jones · St George's, University of London

Jadwiga A. Wedzicha · Imperial College London

Neil Barnes · William Harvey Research Institute

Abstract

Baseline blood eosinophil levels may represent an informative marker for exacerbation reduction with ICS/LABA in patients with COPD and a history of moderate/severe exacerbations.

Topics & Keywords

Chronic Obstructive Pulmonary Disease (COPD) Research Asthma and respiratory diseases Respiratory Support and Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Thorax

Volume 71, Issue 2, pp. 118-125

DOI: 10.1136/thoraxjnl-2015-207021

Field-Weighted Citation Impact: 36.59